- Home
- HOOD vs EW Comparison
HOOD vs EW Comparison
Compare HOOD & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOD
- EW
- Stock Information
- Founded
- HOOD 2013
- EW 1958
- Country
- HOOD United States
- EW United States
- Employees
- HOOD N/A
- EW N/A
- Industry
- HOOD Computer Software: Prepackaged Software
- EW Industrial Specialties
- Sector
- HOOD Technology
- EW Health Care
- Exchange
- HOOD Nasdaq
- EW Nasdaq
- Market Cap
- HOOD 54.5B
- EW 44.8B
- IPO Year
- HOOD 2021
- EW 2000
- Fundamental
- Price
- HOOD $78.50
- EW $73.83
- Analyst Decision
- HOOD Buy
- EW Buy
- Analyst Count
- HOOD 23
- EW 20
- Target Price
- HOOD $63.71
- EW $80.20
- AVG Volume (30 Days)
- HOOD 35.2M
- EW 3.7M
- Earning Date
- HOOD 08-06-2025
- EW 07-23-2025
- Dividend Yield
- HOOD N/A
- EW N/A
- EPS Growth
- HOOD 1117.91
- EW 200.69
- EPS
- HOOD 1.75
- EW 7.02
- Revenue
- HOOD $3,260,000,000.00
- EW $5,522,300,000.00
- Revenue This Year
- HOOD $28.02
- EW $11.81
- Revenue Next Year
- HOOD $15.11
- EW $9.54
- P/E Ratio
- HOOD $44.96
- EW $10.45
- Revenue Growth
- HOOD 59.65
- EW 8.23
- 52 Week Low
- HOOD $13.98
- EW $58.93
- 52 Week High
- HOOD $79.32
- EW $95.25
- Technical
- Relative Strength Index (RSI)
- HOOD 71.28
- EW 39.86
- Support Level
- HOOD $72.86
- EW $72.42
- Resistance Level
- HOOD $75.59
- EW $76.62
- Average True Range (ATR)
- HOOD 3.69
- EW 1.38
- MACD
- HOOD -0.05
- EW -0.51
- Stochastic Oscillator
- HOOD 93.71
- EW 23.34
About HOOD Robinhood Markets Inc.
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.